Development of inorganic nanoparticles for radionuclide therapy in cancer treatment

Radionuclide therapy is an important cancer treatment modality that makes use of the local irradiation from radionuclides at the tumor sites. Radiopharmaceuticals are normally composed of three components: radionuclide, carrier and tumor targeting agent. In terms of the radionuclide carriers, macrocyclic and acyclic chelators are commonly used...